Looking to the future of atopic dermatitis treatment, Drs Kiracofe and Murase offer concluding remarks on current unmet needs, the benefits of treatment guidelines, and the importance of treating itch in patients who are or may become pregnant.
Experts in dermatology comment on the patient considerations required when deciding on systemic treatment for basal cell carcinoma.
Dr. Latanya Benjamin, MD, FAAD, FAAP, discusses the role of topical ruxolitinib cream in managing vitiligo and its effectiveness in a 25-year-old female patient.
Catch up on coverage from the third day of the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.
Adhering to a Mediterranean diet and incorporating omega-3 supplements led to noticeable improvements in acne severity, reducing both inflammatory and non-inflammatory lesions in patients.
In a recent study, authors argue that psychosocial impacts should be at the forefront of the discussion in acne scarring, noting that psychopharmacological management may be necessary in instances of severe psychiatric comorbidities.
Ronda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.
Neal Bhatia, MD, shares his insights on successfully navigating AAD and his session highlights on office politics.
Jared Gollob, MD, Chief Medical Officer of Kymera Therapeutics, spoke with Dermatology Times to discuss these trial results.
Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide impressions to the case and take-home messages for dermatologists and rheumatologists treating psoriasis.
Understanding the underlying motivation for seeking out minimally invasive cosmetic procedures is important to provide individualized and holistic care to patients.
A study finds low risk of malignancy from secukinumab treatment for psoriasis, psoriatic arthritis and ankylosing spondylitis patients, despite limited data.
Jonathan Silverberg, MD, PhD, MPH, presented his tips for effectively treating atopic dermatitis without worsening autoimmune comorbidities.
Saranya Wyles, MD, PhD, offers guidance on integrating advanced skincare technologies into their practices and the importance of staying updated through events like the Science of Skincare summit.
Placental tissues provide a promising alternative for addressing cutaneous reconstruction while maintaining the most cosmetically pleasing outcome.
Pustular psoriasis (PP) is a rare and potentially serious inflammatory skin disorder affecting about 1% of patients with psoriasis.
Earn CME credit and learn how to optimize a multimodal treatment approach for hidradenitis suppurativa.
FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.
Shah discusses the science behind his products, as well as the challenges he didn’t anticipate when launching Remedy.
Ronda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.
Caleb Kovell, MD and Junqian Zhang, MD demonstrated how teaming up increases the likelihood for positive patient outcomes in Mohs cases on the genitalia and perianal region.
She shares her top 5 considerations for all dermatology drug prescribers.
Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.
Amy B. Lewis, MD, explores the evolution of aesthetic dermatology, delving into injection sophistication, devices, and top procedures.